Published in Obstet Gynecol on December 01, 2008
Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women. Obstet Gynecol (2010) 1.94
Updating the natural history of human papillomavirus and anogenital cancers. Vaccine (2012) 1.65
The role of co-factors in the progression from human papillomavirus infection to cervical cancer. Gynecol Oncol (2012) 1.07
Increasing rates of cervical cancer in young women in England: an analysis of national data 1982-2006. Br J Cancer (2011) 1.00
Lessons from practice: risk of CIN 3 or cancer associated with an LSIL or HPV-positive ASC-US screening result in women aged 21 to 24. J Low Genit Tract Dis (2010) 0.93
HPV mRNA is more specific than HPV DNA in triage of women with minor cervical lesions. PLoS One (2014) 0.87
Compliance with cervical cancer screening and human papillomavirus testing guidelines among insured young women. Am J Obstet Gynecol (2013) 0.86
HPV prevalence at enrollment and baseline results from the Carolina Women's Care Study, a longitudinal study of HPV persistence in women of college age. Int J Womens Health (2013) 0.85
HPV infection and cervical neoplasia: associated risk factors. Infect Agent Cancer (2015) 0.82
Human papillomavirus disease and vaccines in adolescents. Adolesc Med State Art Rev (2010) 0.80
Condom and oral contraceptive use and risk of cervical intraepithelial neoplasia in Australian women. J Gynecol Oncol (2014) 0.75
Clinical Utility of Molecular Biomarkers in Cervical Squamous Intraepithelial Lesions in a Young Adult Population. J Low Genit Tract Dis (2016) 0.75
The detection of hTERC amplification using fluorescence in situ hybridization in the diagnosis and prognosis of cervical intraepithelial neoplasia: a case control study. World J Surg Oncol (2012) 0.75
Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med (2003) 31.67
Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol (1991) 20.49
Improved amplification of genital human papillomaviruses. J Clin Microbiol (2000) 11.50
Prevalence of HPV infection among females in the United States. JAMA (2007) 10.55
2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol (2007) 6.25
Sexual behavior and selected health measures: men and women 15-44 years of age, United States, 2002. Adv Data (2005) 5.62
Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA (2001) 4.26
The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr (1998) 3.96
Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol (2003) 3.55
Regression of low-grade squamous intra-epithelial lesions in young women. Lancet (2004) 2.98
Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results. J Infect Dis (2004) 2.77
Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol (2003) 2.71
Development and duration of human papillomavirus lesions, after initial infection. J Infect Dis (2005) 2.51
Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine (2006) 2.51
Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities. J Natl Cancer Inst (2005) 2.47
A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol (2003) 2.45
Covariates of cervical cytokine mRNA expression by real-time PCR in adolescents and young women: effects of Chlamydia trachomatis infection, hormonal contraception, and smoking. J Clin Immunol (2006) 1.48
Modifiable risk factors associated with clearance of type-specific cervical human papillomavirus infections in a cohort of university students. Cancer Epidemiol Biomarkers Prev (2005) 1.32
Natural history of cervical human papillomavirus lesions does not substantiate the biologic relevance of the Bethesda System. Obstet Gynecol (1992) 1.26
Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology. Cancer Epidemiol Biomarkers Prev (2005) 1.24
A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus. Cancer Epidemiol Biomarkers Prev (2004) 1.08
Effects of 17beta-estradiol and progesterone on transcription of human papillomavirus 16 E6/E7 oncogenes in CaSki and SiHa cell lines. Int J Gynecol Cancer (2006) 0.97
National and state-specific pregnancy rates among adolescents--United States, 1995-1997. MMWR Morb Mortal Wkly Rep (2000) 0.92
Depot-medroxyprogesterone acetate (DMPA) and risk of invasive squamous cell cervical cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Contraception (1992) 0.91
Co-operation of progestational steroids with epidermal growth factor in activation of gene expression in mammary tumor cells. J Steroid Biochem Mol Biol (1991) 0.85
Oral contraceptives and cervical cancer: critique of a recent review. Contraception (2004) 0.84
Heritable and environmental components in cervical tumors. Int J Cancer (2006) 0.82
Cytologic changes in cervical smears associated with prolonged use of depot-medroxyprogesterone acetate. Cancer (1998) 0.82
Fraction of cervical neoplasias due to human papillomavirus 16 and 18 in vaccine trials. Int J Cancer (2008) 0.81
Oestrogen and progesterone increase the levels of apoptosis induced by the human papillomavirus type 16 E2 and E7 proteins. J Gen Virol (2001) 0.81
Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet (2007) 7.22
Regression of low-grade squamous intra-epithelial lesions in young women. Lancet (2004) 2.98
Phenotypic predictors of response to simvastatin therapy among African-Americans and Caucasians: the Cholesterol and Pharmacogenetics (CAP) Study. Am J Cardiol (2006) 2.94
Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection. J Infect Dis (2009) 2.82
Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS (2005) 2.56
Comparison of patient- and clinician-collected anal cytology samples to screen for human papillomavirus-associated anal intraepithelial neoplasia in men who have sex with men. Ann Intern Med (2008) 2.22
Human papillomavirus infection and increased risk of HIV acquisition. A systematic review and meta-analysis. AIDS (2012) 2.15
A comprehensive study of the direct and indirect costs of adult asthma. J Allergy Clin Immunol (2003) 2.11
Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type. J Infect Dis (2004) 2.06
Differential effects of ramipril on ambulatory blood pressure in African Americans and Caucasians. Am J Hypertens (2007) 2.06
Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women. Obstet Gynecol (2010) 1.94
Factors that influence the rate of epithelial maturation in the cervix in healthy young women. J Adolesc Health (2009) 1.89
High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann Intern Med (2003) 1.80
Sexual bridging socially and over time: a simulation model exploring the relative effects of mixing and concurrency on viral sexually transmitted infection transmission. Sex Transm Dis (2006) 1.78
How reliable are tests for trachoma?--a latent class approach. Invest Ophthalmol Vis Sci (2011) 1.65
T cell activation in HIV-seropositive Ugandans: differential associations with viral load, CD4+ T cell depletion, and coinfection. J Infect Dis (2005) 1.63
Screening for asymptomatic Chlamydia infections among sexually active adolescent girls during pediatric urgent care. Arch Pediatr Adolesc Med (2009) 1.56
Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections. PLoS One (2010) 1.55
Quasi-experimental designs in practice-based research settings: design and implementation considerations. J Am Board Fam Med (2011) 1.51
Functional attributes of mucosal immunity in cervical intraepithelial neoplasia and effects of HIV infection. Cancer Res (2004) 1.50
Covariates of cervical cytokine mRNA expression by real-time PCR in adolescents and young women: effects of Chlamydia trachomatis infection, hormonal contraception, and smoking. J Clin Immunol (2006) 1.48
Increased levels of immune activation in the genital tract of healthy young women from sub-Saharan Africa. AIDS (2010) 1.47
Incidence of acute urinary tract infection in young women and use of male condoms with and without nonoxynol-9 spermicides. Epidemiology (2002) 1.47
Association of attitudes and beliefs towards antiretroviral therapy with HIV-seroprevalence in the general population of Kisumu, Kenya. PLoS One (2009) 1.45
An early view of the international Sjögren's syndrome registry. Arthritis Rheum (2009) 1.43
Long-term incidence of cervical cancer in women with human immunodeficiency virus. Cancer (2009) 1.42
Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting. Obstet Gynecol (2009) 1.41
What sexually transmitted disease screening method does the adolescent prefer? Adolescents' attitudes toward first-void urine, self-collected vaginal swab, and pelvic examination. Arch Pediatr Adolesc Med (2002) 1.40
High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy. Sex Transm Dis (2004) 1.39
Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3. J Natl Cancer Inst (2012) 1.38
Audio computer-assisted self-interviewing in reproductive health research: reliability assessment among women in Harare, Zimbabwe. Contraception (2006) 1.37
Phosphatidylethanol (PEth) as a biomarker of alcohol consumption in HIV-positive patients in sub-Saharan Africa. Alcohol Clin Exp Res (2011) 1.33
Performance characteristics of anal cytology and human papillomavirus testing in patients with high-resolution anoscopy-guided biopsy of high-grade anal intraepithelial neoplasia. Dis Colon Rectum (2009) 1.32
Human papillomavirus infection and abnormal cytology of the anus in HIV-infected and uninfected adolescents. AIDS (2003) 1.31
The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer. Obstet Gynecol (2010) 1.25
Progression of anal high-grade squamous intraepithelial lesions to invasive anal cancer among HIV-infected men who have sex with men. Int J Cancer (2013) 1.25
Risk of high-grade squamous intraepithelial lesion in HIV-infected adolescents. J Infect Dis (2004) 1.23
Relationship of atypical glandular cell cytology, age, and human papillomavirus detection to cervical and endometrial cancer risks. Obstet Gynecol (2010) 1.22
Determination of cytokine protein levels in cervical mucus samples from young women by a multiplex immunoassay method and assessment of correlates. Clin Vaccine Immunol (2007) 1.22
Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study). Sex Transm Dis (2011) 1.21
Self-collected versus clinician-collected anal cytology specimens to diagnose anal intraepithelial neoplasia in HIV-positive men. J Acquir Immune Defic Syndr (2004) 1.18
Sexual seroadaptation: lessons for prevention and sex research from a cohort of HIV-positive men who have sex with men. PLoS One (2010) 1.18
Association between toll-like receptor expression and human papillomavirus type 16 persistence. Int J Cancer (2011) 1.17
Concordance and transmission of human papillomavirus within heterosexual couples observed over short intervals. J Infect Dis (2013) 1.17
Patients' perspectives on nonadherence to statin therapy: a focus-group study. Perm J (2010) 1.12
Anal intraepithelial neoplasia in a multisite study of HIV-infected and high-risk HIV-uninfected women. AIDS (2009) 1.12
Phase 2a study assessing colonization efficiency, safety, and acceptability of Lactobacillus crispatus CTV-05 in women with bacterial vaginosis. Sex Transm Dis (2010) 1.11
Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California. Cancer Epidemiol Biomarkers Prev (2011) 1.08
Human papillomavirus concordance in heterosexual couples. J Adolesc Health (2010) 1.07
Higher levels of cervicovaginal inflammatory and regulatory cytokines and chemokines in healthy young women with immature cervical epithelium. J Reprod Immunol (2010) 1.07
The diaphragm and lubricant gel for prevention of cervical sexually transmitted infections: results of a randomized controlled trial. PLoS One (2008) 1.06
Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infection. Am J Pathol (2010) 1.05
Participation of Asian-American women in cancer chemoprevention research: physician perspectives. Cancer (2005) 1.05
Patterns and predictors of adherence to diaphragm use in a phase III trial in sub-Saharan Africa: a trajectory analysis. J Acquir Immune Defic Syndr (2009) 1.05
Incidence of anal cytological abnormalities in a cohort of human immunodeficiency virus-infected women. Cancer Epidemiol Biomarkers Prev (2003) 1.04
Comparison of natural histories of human papillomavirus detected by clinician- and self-sampling. Int J Cancer (2010) 1.04
Commentary on Schroder et al. (2003a, 2003b). Ann Behav Med (2005) 1.03
Applications of continuous time hidden Markov models to the study of misclassified disease outcomes. Stat Med (2003) 1.03
Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe. Sex Transm Dis (2009) 1.03
Cervical cytology specimen adequacy: patient management guidelines and optimizing specimen collection. J Low Genit Tract Dis (2008) 1.01
Failure to comply with NCCN guidelines for the management of pancreatic cancer compromises outcomes. HPB (Oxford) (2012) 0.99
Intrauterine contraception: evaluation of clinician practice patterns in Kaiser Permanente Northern California. Contraception (2007) 0.98
Diminished IFN-gamma and IL-10 and elevated Foxp3 mRNA expression in the cervix are associated with CIN 2 or 3. Int J Cancer (2009) 0.98
Participation of Asian-American women in cancer treatment research: a pilot study. J Natl Cancer Inst Monogr (2005) 0.98
Do hospitals that serve a high percentage of Medicaid patients perform well on evidence-based guidelines for colon cancer care? J Health Care Poor Underserved (2013) 0.97
Effect of diaphragm and lubricant gel provision on human papillomavirus infection among women provided with condoms: a randomized controlled trial. Obstet Gynecol (2008) 0.97
Risk factors for anal HPV infection and anal precancer in HIV-infected men who have sex with men. J Infect Dis (2013) 0.97
What factors influence minority use of National Cancer Institute-designated cancer centers? Cancer (2013) 0.95
Human papillomavirus genotype attribution and estimation of preventable fraction of anal intraepithelial neoplasia cases among HIV-infected men who have sex with men. J Infect Dis (2012) 0.95
A phase I randomized placebo controlled trial of the safety of 3% SPL7013 Gel (VivaGel®) in healthy young women administered twice daily for 14 days. PLoS One (2011) 0.95
Revised terminology for cervical histopathology and its implications for management of high-grade squamous intraepithelial lesions of the cervix. Obstet Gynecol (2012) 0.94
Isotretinoin for low-grade cervical dysplasia in human immunodeficiency virus-infected women. Obstet Gynecol (2002) 0.94
Phase 1 dose-ranging safety trial of Lactobacillus crispatus CTV-05 for the prevention of bacterial vaginosis. Sex Transm Dis (2009) 0.94
Cytomegalovirus impairs cytotrophoblast-induced lymphangiogenesis and vascular remodeling in an in vivo human placentation model. Am J Pathol (2012) 0.93
Concomitant anal and cervical human papillomavirusV infections and intraepithelial neoplasia in HIV-infected and uninfected women. AIDS (2013) 0.93
Evaluating change in health-related quality of life in adult rhinitis: responsiveness of the Rhinosinusitis Disability Index. Health Qual Life Outcomes (2005) 0.93
Impact of paid sick leave policy: a social planner's perspective. Am J Public Health (2013) 0.92
Shamba Maisha: randomized controlled trial of an agricultural and finance intervention to improve HIV health outcomes. AIDS (2015) 0.91
Projected future increase in aging hepatitis C virus-infected liver transplant candidates: a potential effect of hepatocellular carcinoma. Liver Transpl (2012) 0.91
Human papillomavirus genotyping, human papillomavirus mRNA expression, and p16/Ki-67 cytology to detect anal cancer precursors in HIV-infected MSM. AIDS (2012) 0.91
Atypical glandular cells of undetermined significance (AGUS): Interobserver reproducibility in cervical smears and corresponding thin-layer preparations. Am J Clin Pathol (2002) 0.91
Seventh edition (2010) of the AJCC/UICC staging system for gastric adenocarcinoma: is there room for improvement? Ann Surg Oncol (2012) 0.91